Effects of deoxyspergualin (DSG) administered in the chronic phase following kidney transplantation.
Fudaba
Y
Y
Second Department of Surgery, Hiroshima University School of Medicine, Japan.
Fukuda
Y
Y
Yamamoto
H
H
Ohdan
H
H
Shintaku
S
S
Shibata
S
S
Miyata
Y
Y
Marubayashi
S
S
Asahara
T
T
Dohi
K
K
D002908:Chronic Disease; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus; D008775:Methylprednisolone